Source: ERJ Open Res, 5 (3) 00118-2019; 10.1183/23120541.00118-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yet H. Khor, Elisabetta A. Renzoni, Dina Visca, Christine F. McDonald, Nicole S. L. Goh. Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns. ERJ Open Res, 5 (3) 00118-2019; 10.1183/23120541.00118-2019

Member's Comments

No comment yet.

Related content which might interest you: Fibrosing interstitial lung diseases: knowns and unknowns Source: Eur Respir Rev, 28 (151) 180100; 10.1183/16000617.0100-2018 Year: 2019 Debate – Controversies in interstitial lung disease Source: ERS webinar 2021 Access for REGISTERED non-members Year: 2021 Drug-induced interstitial lung disease: known knowns and known unknowns Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 Oxygen therapy for interstitial lung disease: a systematic review Source: Eur Respir Rev 2017; 26: 160080 Year: 2017 Treatment of combined pulmonary fibrosis and emphysema Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Multidisciplinary board for interstitial lung disease: Relevance for real life? Source: International Congress 2015 – New insights into IIPs Year: 2015 Interstitial lung diseases and COVID-19: myths and reality Source: Virtual Congress 2021 – Chinese programme 2021 Year: 2021 Teleradiology in interstitial lung disease: first experiences Source: International Congress 2017 – Rare diseases Year: 2017 Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs) Source: International Congress 2016 – The future of lung function is beginning now Year: 2016 Interstitial lung disease (ILD) and multicompartment assessment of CTD: where should the respiratory physician begin? Source: Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease Year: 2020 Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Temporal variations of oscillometric reactance in COPD and ILD Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 Interstitial lung disease: new challenges and evolving phenotypes Source: Eur Respir Rev 2009; 19: 91-93 Year: 2010 Exercise training in patients with interstitial lung disease (ILD): Can reponders be distinguished from non-responders Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015 Biomarkers for pulmonary hypertension in interstitial lung disease Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 A new spirometry-based algorithm to predict occupational pulmonary restrictive impairment Source: International Congress 2015 – Occupational and environmental cohort investigations and population studies Year: 2015